Hyperthyroidism in a 15-year-old adolescent treated with Dupilumab for severe allergic asthma and atopic dermatitis

Tosca, Maria Angela; Olcese, Roberta; Girosi, Donata; Casalini, Emilio; Scaglione, Marco; Ciprandi, Giorgio.
Allergol. immunopatol ; 51(3): 181-185, 01 mayo 2023. ilus, tab
Artículo en Inglés | IBECS (España) | ID: ibc-219828

Documentos relacionados

  1. Corneal Complications Related to Dupilumab Use.
  2. Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and Aetiology.
  3. [Psoriasis in dupilumab-treated atopic dermatitis].
  4. Systemic Biologic Management of Atopic Dermatitis.
  5. Safety of dupilumab in a 5-month-old infant with severe atopic dermatitis.
  6. Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis.
  7. Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort.
  8. Eruptive keratoacanthomas associated with dupilumab therapy.
  9. Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience.
  10. Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience.